https://www.bloomberg.com/authors/AXDw-uykeeQ/amber-tonghttps://www.bloomberg.com/feeds/static/images/bloomberg_logo_black.pnghttps://www.bloomberg.com/authors/AXDw-uykeeQ/amber-tongRSS for NodeMon, 01 Sep 2025 04:31:48 GMThttps://www.bloomberg.com/news/articles/2025-08-29/eli-lilly-partners-with-china-tech-giant-for-obesity-drug-saleshttps://www.bloomberg.com/news/articles/2025-08-29/eli-lilly-partners-with-china-tech-giant-for-obesity-drug-salesFri, 29 Aug 2025 07:54:45 GMTEli Lilly & Co. Mounjaro brand tirzepatide medication.https://www.bloomberg.com/news/articles/2025-08-28/hong-kong-judges-to-decide-jimmy-lai-s-fate-as-key-trial-wrapshttps://www.bloomberg.com/news/articles/2025-08-28/hong-kong-judges-to-decide-jimmy-lai-s-fate-as-key-trial-wrapsThu, 28 Aug 2025 05:23:36 GMTJimmy Lai in 2021. Photographer: Chan Long Hei/Bloomberghttps://www.bloomberg.com/news/articles/2025-08-27/akeso-s-lung-cancer-drug-hits-key-goal-in-china-studyhttps://www.bloomberg.com/news/articles/2025-08-27/akeso-s-lung-cancer-drug-hits-key-goal-in-china-studyWed, 27 Aug 2025 01:43:20 GMThttps://www.bloomberg.com/news/articles/2025-08-18/csl-to-spinoff-vaccine-unit-seqirus-plans-487-million-buybackhttps://www.bloomberg.com/news/articles/2025-08-18/csl-to-spinoff-vaccine-unit-seqirus-plans-487-million-buybackMon, 18 Aug 2025 21:52:13 GMT28 year-old Tara Seaton, an Australia Post employee, looks away as Luiza Duszynski, a nursing supervisor at the Royal Adelaide Hospital, injects her with CSL Ltd.'s H1N1 vaccine in Adelaide, Australia, on Wednesday, July 22, 2009. The first human trials of a swine-flu vaccine began today in Australia as deaths and infections from the H1N1 virus mount worldwide, intensifying demand for a protective shot.https://www.bloomberg.com/news/articles/2025-08-15/hk-court-hears-final-arguments-in-landmark-trial-of-jimmy-laihttps://www.bloomberg.com/news/articles/2025-08-15/hk-court-hears-final-arguments-in-landmark-trial-of-jimmy-laiFri, 15 Aug 2025 01:51:13 GMTJimmy Lai in 2021. Photographer: Chan Long Hei/Bloomberghttps://www.bloomberg.com/news/articles/2025-08-15/chinese-drugmaker-aiming-to-sell-obesity-meds-soars-in-hk-debuthttps://www.bloomberg.com/news/articles/2025-08-15/chinese-drugmaker-aiming-to-sell-obesity-meds-soars-in-hk-debutFri, 15 Aug 2025 01:37:41 GMThttps://www.bloomberg.com/news/articles/2025-08-12/eli-lilly-pfizer-seek-spot-in-china-private-insurance-cataloghttps://www.bloomberg.com/news/articles/2025-08-12/eli-lilly-pfizer-seek-spot-in-china-private-insurance-catalogTue, 12 Aug 2025 09:21:27 GMThttps://www.bloomberg.com/news/articles/2025-08-11/chinese-flu-shot-maker-soars-in-hong-kong-trading-debuthttps://www.bloomberg.com/news/articles/2025-08-11/chinese-flu-shot-maker-soars-in-hong-kong-trading-debutMon, 11 Aug 2025 01:53:37 GMThttps://www.bloomberg.com/news/newsletters/2025-08-07/hong-kong-black-rain-how-confluence-of-events-resulted-in-epic-downpourhttps://www.bloomberg.com/news/newsletters/2025-08-07/hong-kong-black-rain-how-confluence-of-events-resulted-in-epic-downpourThu, 07 Aug 2025 03:50:07 GMTRainwater rushes down a flight of stairs in Hong Kong on Aug. 5. Photographer: Yik Yeung-man/Bloomberghttps://www.bloomberg.com/news/articles/2025-08-05/innogen-pharma-said-to-take-orders-this-week-for-hong-kong-ipohttps://www.bloomberg.com/news/articles/2025-08-05/innogen-pharma-said-to-take-orders-this-week-for-hong-kong-ipoTue, 05 Aug 2025 11:11:01 GMThttps://www.bloomberg.com/news/articles/2025-07-30/fda-s-vinay-prasad-exits-after-sarepta-gene-therapy-controversyhttps://www.bloomberg.com/news/articles/2025-07-30/fda-s-vinay-prasad-exits-after-sarepta-gene-therapy-controversyWed, 30 Jul 2025 01:37:47 GMTVinay Prasadhttps://www.bloomberg.com/news/articles/2025-07-28/wuxi-apptec-half-year-revenue-beats-despite-tariff-threathttps://www.bloomberg.com/news/articles/2025-07-28/wuxi-apptec-half-year-revenue-beats-despite-tariff-threatMon, 28 Jul 2025 09:45:22 GMThttps://www.bloomberg.com/news/articles/2025-07-28/hengrui-shares-jump-on-gsk-deal-worth-up-to-12-billionhttps://www.bloomberg.com/news/articles/2025-07-28/hengrui-shares-jump-on-gsk-deal-worth-up-to-12-billionMon, 28 Jul 2025 02:54:34 GMThttps://www.bloomberg.com/news/articles/2025-07-16/hengrui-s-obesity-drug-rivals-zepbound-in-late-stage-china-trialhttps://www.bloomberg.com/news/articles/2025-07-16/hengrui-s-obesity-drug-rivals-zepbound-in-late-stage-china-trialWed, 16 Jul 2025 03:00:44 GMThttps://www.bloomberg.com/news/features/2025-07-13/china-drugmakers-catching-up-to-us-big-pharma-with-new-medicine-innovationhttps://www.bloomberg.com/news/features/2025-07-13/china-drugmakers-catching-up-to-us-big-pharma-with-new-medicine-innovationSun, 13 Jul 2025 21:00:20 GMTA production laboratory for CAR-T cell therapies in Nanjing, China, on June 9. The world’s strictest regulatory agencies increasingly view Chinese drugs as generally promising enough to justify devoting extra resources to speed up their review.https://www.bloomberg.com/news/newsletters/2025-07-10/more-comfortable-alternative-to-pap-smear-test-a-padhttps://www.bloomberg.com/news/newsletters/2025-07-10/more-comfortable-alternative-to-pap-smear-test-a-padThu, 10 Jul 2025 10:00:22 GMTA PadX HPV test kit. Source: PadXhttps://www.bloomberg.com/news/articles/2025-07-09/merck-agrees-to-buy-verona-pharma-for-about-10-billionhttps://www.bloomberg.com/news/articles/2025-07-09/merck-agrees-to-buy-verona-pharma-for-about-10-billionWed, 09 Jul 2025 10:40:21 GMThttps://www.bloomberg.com/news/articles/2025-07-09/merck-nears-10-billion-deal-for-drugmaker-verona-ft-reportshttps://www.bloomberg.com/news/articles/2025-07-09/merck-nears-10-billion-deal-for-drugmaker-verona-ft-reportsWed, 09 Jul 2025 05:16:19 GMThttps://www.bloomberg.com/news/articles/2025-07-06/china-imposes-reciprocal-curbs-on-eu-medical-device-procurementhttps://www.bloomberg.com/news/articles/2025-07-06/china-imposes-reciprocal-curbs-on-eu-medical-device-procurementSun, 06 Jul 2025 07:30:09 GMThttps://www.bloomberg.com/news/newsletters/2025-07-01/china-adds-own-homegrown-weight-loss-drug-mazdutidehttps://www.bloomberg.com/news/newsletters/2025-07-01/china-adds-own-homegrown-weight-loss-drug-mazdutideTue, 01 Jul 2025 13:00:31 GMTA resident uses exercise equipment in Shanghai.